Students for Life threatens FDA lawsuit over mifepristone environmental reviews
Pro-life group claims agency skipped Endangered Species Act consultation before approving the abortion pill.
What to know
- Students for Life filed a notice of intent to sue the FDA for allegedly violating the Endangered Species Act by not consulting wildlife agencies before approving mifepristone in 2000.
- The group cites studies showing anti-progesterone activity in U.S. water samples, arguing the drug poses environmental risks to waterways and federally protected species.
- The FDA has 60 days to respond before SFLA proceeds with litigation; the filing timing coincides with FDA nominee Dr. Heidi Overton's Senate confirmation hearing.
Kristan Hawkins President, Students for Life of AmericaStudents for Life of America (SFLA) Pro-life advocacy organization
Dr. Heidi Overton FDA nominee for Senate confirmationFood and Drug Administration (FDA) Federal regulatory agency
How it unfolded 2 developments, newest first · click a bar or a number to jump articles
-
1
Hawkins frames lawsuit as response to water contamination risk
SFLA President Kristan Hawkins argues that if 600,000 to 700,000 chemical abortions occur annually at home over weeks, the drug must be entering the water supply, warranting federal review. The FDA has 60 days to respond before litigation.
“Where do all the babies go in chemical abortions? If we're talking 600,000 to 700,000 abortions a year being induced with chemical abortion pills, where are they happening?”
— Kristan Hawkins -
2
Students for Life files notice of intent to sue FDA
Students for Life of America filed a formal notice of intent to sue the FDA over alleged failure to conduct required environmental testing of mifepristone, citing six studies including one reporting anti-progesterone activity in water samples from three U.S. cities. The filing comes hours before FDA nominee Dr. Heidi Overton's Senate confirmation hearing.
“We expect these environmental concerns to be taken seriously. I know Dr. Overton is aware of these concerns. Or we expect to see the Trump FDA in court. That's where this will end.”
— Kristan Hawkins -
background
FDA rejects Students for Life's environmental petition — In response to a citizen petition, the FDA rejected Students for Life's legal argument that it was required to consult with wildlife protection agencies before approving mifepristone.
-
background
FDA approves mifepristone without Endangered Species Act consultation — The FDA approved mifepristone in 2000 without consulting the U.S. Fish and Wildlife Service or the National Marine Fisheries Service about potential effects on federally protected species, according to Students for Life's allegations.
Also covered reported alongside — the timeline has no entry for these yet
-
first by LifeNews.com, 20h ago · also Fox News, The Hill
2 more headlines